Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menggang Yu

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
Mayo Clinic Proceedings|December 5, 2020
Thirty-Day Re-observation, Chronic Re-observation, and Neighborhood DisadvantageAnn M Sheehy, W Ryan Powell, Farah A Kaiksow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2010
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumorsE Gabriela Chiorean, Srikar Malireddy, Anne E Younger, et al.
Breast Cancer Research : BCR|January 21, 2017
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cellsCraig E Barcus, Kathleen A O'Leary, Jennifer L Brockman, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2017
Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomasHuaising C Ko, Paul M Harari, Ryan M Sacotte, et al.
The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.
Cancer Cell|January 18, 2014
CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Head and Neck Pathology|August 5, 2024
Morphologic Spectrum of HPV-associated Sinonasal CarcinomasTarek Abi-Saab, Taja Lozar, Yi Chen, et al.
JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.
Cancer Cell|August 2, 2016
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and MetastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|December 5, 2020
Thirty-Day Re-observation, Chronic Re-observation, and Neighborhood DisadvantageAnn M Sheehy, W Ryan Powell, Farah A Kaiksow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2010
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumorsE Gabriela Chiorean, Srikar Malireddy, Anne E Younger, et al.
Breast Cancer Research : BCR|January 21, 2017
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cellsCraig E Barcus, Kathleen A O'Leary, Jennifer L Brockman, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2017
Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomasHuaising C Ko, Paul M Harari, Ryan M Sacotte, et al.
The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.
Cancer Cell|January 18, 2014
CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Head and Neck Pathology|August 5, 2024
Morphologic Spectrum of HPV-associated Sinonasal CarcinomasTarek Abi-Saab, Taja Lozar, Yi Chen, et al.
JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.
Cancer Cell|August 2, 2016
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and MetastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Pageof 18